Enquirer: Venture capital firm relocates to 1819 Innovation Hub
Orange Grove Bio plans to partner with UC to cultivate biotech landscape
A venture capital firm is relocating its headquarters from New York City to the University of Cincinnati 1819 Innovation Hub, the Cincinnati Enquirer reported.
Orange Grove Bio, which invests mainly in therapeutic drug companies, cited several reasons for moving to Cincinnati including proximity to other research hubs in the Midwest, the cost of living and quality of life in the area, said Ryan Fox, Orange Grove's chief business operations officer.
In Cincinnati, Orange Grove will partner with UC to help cultivate “the increasingly robust Cincinnati biotech landscape.”
The company plans to start with six to eight employees in Cincinnati. It expects to hire as many as 30 to 50 employees over the next several years, Fox said.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's undergraduate, graduate and medical students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.